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An unusual acute myeloid leukemia associated with hyper
IgE: another case of AML-M5c?
Although a large number of histiocytic diseases have been
described, their classification remains controversial1,2 and only
a few cases of primary histiocytic disorders presenting with
or evolving into an overt leukemic phase - AML-M5c – have
been reported.3,9 We describe a leukemia with unusual clin-
ical and laboratory features whose diagnosis is compatible
with AML-M5c.
A 50-year old white male was studied because of anemia and
thrombocytopenia. Clinically, only anemia-related symptoms
were found and the physical examination yielded negative
results. Blood counts were: hemoglobin (Hb) 5.9 g/dL, platelets
(PLT) 48×109/L, white blood cells (WBC) 6.8×109/L (neutrophils
63%, eosinophils 1%, lymphocytes 27%, monocytes 9%). Bio-
chemical tests were normal except for increased serum lactic
dehydrogenase (744 U/L; normal range 225-450 U/L), ferritin
(523 ng/mL; normal range 12-200 ng/mL) and lysozyme (15
µg/mL; normal values <12 µg/mL). There was a polyclonal hyper
IgE (2,198 IU × 2/mL, normal values < 100 IU × 2/mL), without
any clinical or laboratory evidence of parasitosis or atopic con-
ditions. The bone marrow (BM) film showed 24% blasts, 44%
granulocytic cells, 2% monocytes, 16% lymphocytes, 3% plas-
ma cells and 11% erythroid precursors. Blasts were markedly
polymorphic and hemophagocytosed other blood cells; a few
mature-looking histiocytes were also found (Figure 1A). The BM
biopsy showed a hypercellular and disorganized marrow with
excess of blasts (Figure 1B). The megakaryocytic and erythroid
lineages showed dystrophic elements while granulocytic cells
matured normally. Ultrastructural studies did not shown Birbeck
granules or ferritin deposits (Figure 1C). BM cells had a normal
Table 1. Blast cell cytochemical, immunophenotypic and
immunohistochemical studies.
Positive Negative
Cytochemistry Acid phosphatase Naphthol AS-D chloroacetate esterase
α-naphthyl butyrate Myeloperoxidase
esterase* Sudan Black
α-naphthyl acetate 
esterase*
Periodic acid schiff
Immunophenotyping CD4 CD1a CD41
CD11a CD2 CD45RO
CD11c CD3 CD56
CD13 CD5 CD57
CD15 CD7 CD61
CD16 CD8 CD64
CD29 CD10 CDw65
CD33 CD11b CD66b
CD35 CD14 Glycophorin  A
CD38 CD19 HLA-DR
CD42 CD20 Ig heavy chains
CD45 CD22 Ig light chains
CD45RA CD25 TCRαβ
CD54 CD54 TCRγδ
CD117 CD34
Immunohistochemistry CD68 CD20 CD61
Lysozyme CD45RO VWF
Ig, Immunoglobulins; TCR, T-cell receptor; vWF, von Willebrand Factor; *Inhibited by
sodium fluoride.
Figure 1. Bone marrow film (Leishmann´s
stain) showing polymorphic medium to large
sized blast cells, one of which is hemophago-
cytosing an erythroblast (panel A); blast cells
had a relatively abundant cytoplasm with mod-
erate to strong basophilia, sometimes with
scattered vacuoles and fine granules. The
nucleus was usually round, sometimes eccen-
tric and had reticulated chromatin, usually with
one or more well defined nucleoli. Some
mature-looking histiocytes with hemophago-
cytic features were also found. As shown in
panel B, bone marrow trephine biopsy revealed
a hypercellular disorganized marrow with
CD68+ blast cells. Ultrastructural microscopy
studies illustrated in panel C showed blast
cells with round or oval, sometimes irregularly
shaped nuclei, with a marked predominance of
euchromatin and large nucleoli: the cytoplasm
was rich in cytoplasmic organelles. Birbeck´s
granules, azurophilic granules or other specif-
ic granules were not found, neither were fer-
ritin deposits. Occasionally, hemophagocytic
features were observed. Representative dot
plots illustrating some of the immunopheno-
typing features of the blast cells are displayed
in panel D.
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chromosomal constitution. Blast cell cytochemical, immunophe-
notypic and immunohistochemical features are illustrated in
Table 1 and Figure 1D. Blasts expressed a low intensity of CD45
and myeloid associated markers such as CD13, CD15, CD33 and
CD117. In spite of the negativity for CD14 and CD11b, they were
positive for other markers that are usually found on monocyte-
macrophage cells such as surface CD4, CD11c, CD16, CD29,
CD35, CD38, CD54, cytoplasmic CD68 and lysozyme. However,
the disease did not fulfill criteria for conventional AML-M4 and
AML-M5 and AML-M5 with erythrophagocytosis was also
excluded due to the lack of t(8;16) in conventional cytogenet-
ics, no cells being available for molecular studies. The diagnosis
of an AML-M6 was excluded based on FAB criteria, negativity
for glycophorin A and absence of ferritin granules. The possibil-
ity of an AML-M7 appeared very unlikely because blasts were
positive only for CD42b, a marker that may also be expressed on
monocytes and macrophages. Taken together, these results sug-
gest that the proliferating cell was an immature cell potential-
ly committed to the monocyte-macrophage lineage. Putative
causes for a secondary histiocytic proliferation were exhaus-
tively ruled out, as was the possibility of a histiocytic lymphoma.
In fact, there was no clinical or laboratory evidence of infectious
diseases or other neoplasms, no organomegaly, adenomegaly,
cutaneous lesions or bone alterations. The diagnosis of a disease
of Langerhans-dendritic cells was excluded based on the nega-
tivity for CD1a and the absence of Birbeck granules. The patient
became dependent on blood transfusions for 4 months. By that
time he had fever and petechiae, Hb 8.6 g/dL, PLT 16×109/L, WBC
7×109/L with 16% of circulating blasts and LDH 4,505 U/L.
Chemotherapy was then proposed but the patient died before
treatment due to a cerebral hemorrhage. Although at diagnosis
the disease was reminiscent of a myelodysplastic syndrome with
excess of blasts it rapidly evolved into an overt acute leukemia
and the data support the hypothesis that this was one of the very
uncommon cases of histiocytic leukemia previously referred to
as AML-M5c. The significance of the associated hyper IgE
remains an open question. As IgE synthesis is selectively pro-
moted by interleukin 4, which is produced by T-cells and stim-
ulates various macrophage functions,10 we speculate that hyper
IgE is related to the immune disturbance associated with the
malignant histiocytic proliferation.
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